GC WellBeing Corporation (KOSDAQ:234690)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Prescription Drugs	134.21B	108.44B	102.95B
Health Functional Food	32.80B	26.41B	17.58B
Unallocated Adjutment	-2.33B	-1.05B	-
Total	164.68B	133.80B	120.53B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec 31, 2023
Overseas	590.13M
South Korea	119.94B
Total	120.53B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error